Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Cases Journal|October 16, 2009
Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo 200) in the treatment of Parkinson's disease: a case seriesKapil D Sethi, Robert A Hauser, Stuart H Isaacson, et al.
Clinical Parkinsonism & Related Disorders|August 29, 2022
Should "on-demand" treatments for Parkinson's disease OFF episodes be used earlier?Stuart H Isaacson, Fernando L Pagan, Mark F Lew, et al.
Parkinsonism & Related Disorders|July 30, 2023
Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's diseaseStuart H Isaacson, Daniel Kremens, Yasar Torres-Yaghi, et al.
Clinical Parkinsonism & Related Disorders|July 27, 2023
Dopamine agonists in Parkinson's disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatmentStuart H Isaacson, Robert A Hauser, Rajesh Pahwa, et al.
Expert Review of Medical Devices|October 25, 2023
Clinical benefit of transcutaneous afferent patterned stimulation (TAPS) in essential tremor patients with high unmet need: a secondary analysis of TAPS studiesStuart H Isaacson, Rajesh Pahwa, Salima Brillman, et al.
Expert Opinion on Pharmacotherapy|March 26, 2025
Management of Parkinson's disease psychosis: first-line antipsychotic selection and rationale for continuing, combining, or switchingStuart H Isaacson, Henry Nasrallah, Rajesh Pahwa, et al.
Clinical Neuropharmacology|June 23, 2016
Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic HypotensionRobert A Hauser, Stephane Heritier, Gerald J Rowse, et al.
International Journal of Psychiatry in Clinical Practice|May 16, 2022
Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosisMarwan Sabbagh, Gary W Small, Stuart H Isaacson, et al.
Neurology and Therapy|July 29, 2022
Screening, Diagnosis, and Management of Parkinson's Disease Psychosis: Recommendations From an Expert PanelRajesh Pahwa, Stuart H Isaacson, Gary W Small, et al.
Neurodegenerative Disease Management|December 3, 2025
Practices and perceptions around splitting of carbidopa/levodopa tablets: a survey of patients and neurologistsRamon L Rodriguez, Stuart H Isaacson, Yasar Torres-Yaghi, et al.
Pageof 9